Michael J Wagner

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Ejection Fraction

Top Venues

Journal for immunotherapy of cancer

Molecular genetics & genomic medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

John J Lim, Eleanor Y Chen, Stephanie K Schaub, Michael J Wagner
Reclassification of a spindle cell sarcoma after identification of a TFG-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma. Molecular genetics & genomic medicine 12 (4) (2024)
John J Lim, Eleanor Y Chen, Stephanie K Schaub, Michael J Wagner
Reclassification of a spindle cell sarcoma after identification of a TFG-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma. Molecular genetics & genomic medicine 12 (4) (2024)
John J Lim, Eleanor Y Chen, Stephanie K Schaub, Michael J Wagner
Reclassification of a spindle cell sarcoma after identification of a TFG-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma. Molecular genetics & genomic medicine 12 (4) (2024)
Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth Trice Loggers, Seth M Pollack, Michael J Wagner, Denise K Reinke, Patrick Schöffski, William D Tap
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth Trice Loggers, Seth M Pollack, Michael J Wagner, Denise K Reinke, Patrick Schöffski, William D Tap
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406). Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Kelly G Paulson, Vinod Ravi, Brian P Rubin, Min Park, Elizabeth T Loggers, Lee D Cranmer, Michael J Wagner
Incidence, demographics, and survival of malignant hemangioendothelioma in the United States. Cancer medicine (2023)
Caleb Kim, Lara E Davis, Catherine M Albert, Brian L Samuels, Jesse L Roberts, Michael J Wagner
Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids? Cancers 15 (20) (2023)
Michael J Wagner, Yuzheng Zhang, Lee D Cranmer, Elizabeth Trice Loggers, R Graeme Black, Sabrina McDonnell, Shannon Maxwell, Rylee Johnson, Roxanne Moore, Pedro Hermida de Viveiros, Lauri Aicher, Kimberly S Smythe, Qianchuan He, Robin L Jones, Seth M Pollack
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Michael J Wagner, Megan Othus, Sandip P Patel, Chris Ryan, Ashish Sangal, Benjamin Powers, G Thomas Budd, Adrienne I Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Kirsten M Leu, Mark Agulnik, Elad Sharon, Edward Mayerson, Melissa Plets, Charles Blanke, Howard Streicher, Young Kwang Chae, Razelle Kurzrock
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). Journal for immunotherapy of cancer 9 (8) (2022)
Siobhan S Pattwell, Sonali Arora, Nicholas Nuechterlein, Michael A Zager, Keith R Loeb, Patrick J Cimino, Nikolas C Holland, Noemi Reche-Ley, Hamid Bolouri, Damian A Almiron Bonnin, Frank Szulzewsky, Vaishnavi V Phadnis, Tatsuya Ozawa, Michael J Wagner, Michael C Haffner, Junyue Cao, Jay Shendure, Eric C Holland
Oncogenic role of a developmentally regulated NTRK2 splice variant. Science advances 8 (40) (2022)
Geoffrey Mitchell, Seth M Pollack, Michael J Wagner
Targeting cancer testis antigens in synovial sarcoma. Journal for immunotherapy of cancer 9 (6) (2021)
Brett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, Rachel M Gittelman, Marissa Vignali, Shihong Zhang, Kevin C Flanagan, Julie Rytlewski, Laura Riolobos, Brian C Schulte, Teresa S Kim, Eleanor Chen, Kimberly S Smythe, Michael J Wagner, Jose G Mantilla, Jean S Campbell, Robert H Pierce, Robin L Jones, Lee D Cranmer, Seth M Pollack
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes. Journal for immunotherapy of cancer 9 (8) (2021)
Michael J Wagner, Seth M Pollack, Lee D Cranmer, Matthew J Thompson, Shannon Maxwell, Stephanie Wright, Ali Raza Khaki, Margaret M Madeleine, Petros Grivas, Nicole M Kuderer, Gary H Lyman, Elizabeth T Loggers
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer investigation 39 (4) (2021)
Michael J Wagner, Robert W Ricciotti, Jose Mantilla, Elizabeth T Loggers, Seth M Pollack, Lee D Cranmer
Response to PD1 inhibition in conventional chondrosarcoma. Journal for immunotherapy of cancer 6 (1) (2018)
Vancheswaran Gopalakrishnan, Behrang Amini, Michael J Wagner, Erica N Nowell, Alexander J Lazar, Patrick P Lin, Robert S Benjamin, Dejka M Araujo
Synovial Sarcoma of the Head and Neck: A Single Institution Review. Sarcoma 2017 (2017)
Gustavo Schvartsman, Michael J Wagner, Behrang Amini, Chrystia M Zobniw, Van Anh Trinh, Andrea G Barbo, Heather Y Lin, Wei-Lien Wang, Anthony Paul Conley, Vinod Ravi, Dejka M Araujo, Maria Alejandra Zarzour, Robert S Benjamin, Shreyaskumar Patel, Neeta Somaiah
Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Scientific reports 7 (1) (2017)